These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 10074215)

  • 41. Epidermal growth factor receptors in human breast cancer: a plea for standardisation of assay methodology.
    Koenders PG; Faverly D; Beex LV; Bruggink ED; Kienhuis CB; Benraad TJ
    Eur J Cancer; 1992; 28(2-3):693-7. PubMed ID: 1591096
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Estradiol, progesterone, and dexamethasone receptors in infiltrating ductal carcinoma].
    Salazar Esquivel EL; Paredes López A; Calzada Sánchez L
    Ginecol Obstet Mex; 1994 Feb; 62():48-51. PubMed ID: 8181773
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Study of the expression on the CD44v5 adhesion molecule in invasive lobular carcinomas of the breast. Association between negativity and cellular S-phase fraction >7%.
    Ruibal A; Arias J; Del Rio MC; Schneider J; Tejerina A
    Int J Biol Markers; 2000; 15(2):195-6. PubMed ID: 10883896
    [No Abstract]   [Full Text] [Related]  

  • 44. Outcomes of breast cancer patients with triple negative receptor status treated with accelerated partial breast irradiation.
    Wilkinson JB; Reid RE; Shaitelman SF; Chen PY; Mitchell CK; Wallace MF; Marvin KS; Grills IS; Margolis JM; Vicini FA
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):e159-64. PubMed ID: 21345613
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunohistochemical analysis of estrogen and progesterone receptors in benign breast diseases.
    Tóth J; De Sombre ER; Greene GL
    Zentralbl Pathol; 1991; 137(3):227-32. PubMed ID: 1931896
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma.
    Khalifeh IM; Albarracin C; Diaz LK; Symmans FW; Edgerton ME; Hwang RF; Sneige N
    Am J Surg Pathol; 2008 Apr; 32(4):544-52. PubMed ID: 18300793
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The prognostic significance of epidermal growth factor receptor (EGFR), C-erbB-2, Ki-67 and PCNA expression in breast cancer.
    Ioachim E; Kamina S; Athanassiadou S; Agnantis NJ
    Anticancer Res; 1996; 16(5B):3141-7. PubMed ID: 8920782
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Detection of steroid hormone receptors in patients with mastopathies and fibroadenomas].
    Meissner J; Kasch R; Splitt G; Gerber B; Rhode E
    Zentralbl Gynakol; 1989; 111(23):1562-6. PubMed ID: 2624008
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Receptor (ER, PgR) levels as prognostic factors in the endocrine therapy of pre- and post-menopausal patients with stage III infiltrative ductal and lobular cancer of the breast].
    Calzada L; Salazar EL; Pedron Nuevo N
    Ginecol Obstet Mex; 1996 Mar; 64():135-9. PubMed ID: 8729191
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Body weight and risk of molecular breast cancer subtypes among postmenopausal Mediterranean women.
    Crispo A; Montella M; Buono G; Grimaldi M; D'Aiuto M; Capasso I; Esposito E; Amore A; Nocerino F; Augustin LS; Giudice A; Di Bonito M; Giuliano M; Forestieri V; De Laurentiis M; Rinaldo M; Ciliberto G; De Placido S; Arpino G
    Curr Res Transl Med; 2016; 64(1):15-20. PubMed ID: 27140595
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Oestrogen receptor and epidermal growth factor receptor expression in male breast carcinoma.
    Fox SB; Rogers S; Day CA; Underwood JC
    J Pathol; 1992 Jan; 166(1):13-8. PubMed ID: 1538271
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nonlinear discriminant analysis and prognostic factor classification in node-negative primary breast cancer using probabilistic neural networks.
    Le Goff JM; Lavayssière L; Rouëssé J; Spyratos F
    Anticancer Res; 2000; 20(3B):2213-8. PubMed ID: 10928180
    [TBL] [Abstract][Full Text] [Related]  

  • 53. TRAIL death receptor-4 expression positively correlates with the tumor grade in breast cancer patients with invasive ductal carcinoma.
    Sanlioglu AD; Korcum AF; Pestereli E; Erdogan G; Karaveli S; Savas B; Griffith TS; Sanlioglu S
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):716-23. PubMed ID: 17512128
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mean nuclear area and metallothionein expression in ductal breast tumors: correlation with estrogen receptor status.
    El Sharkawy SL; Farrag AR
    Appl Immunohistochem Mol Morphol; 2008 Mar; 16(2):108-12. PubMed ID: 18227734
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Change of influence of prognostic markers on metastasis free interval during and after adjuvant tamoxifen therapy in breast cancer patients.
    Abu Rabi Z; Todorovic-Rakovic N; Markicevic M; Stamatovic L; Vujasinovic T; Nikolic-Vukosavljevic D
    J BUON; 2013; 18(2):321-7. PubMed ID: 23818341
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A comparison of the patterns of laminin expression in fibroadenoma, fibrocystic diseases, pre-invasive and invasive ductal breast carcinoma.
    Zheng WQ; Looi LM; Cheah PL
    Pathology; 2001 Aug; 33(3):303-6. PubMed ID: 11523929
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Estrogen dependence of primary breast cancer--correlation with histologic type and grade.
    Nikolić-Vukosavljević D; Branković-Magić M; Polić D; Vlajić M; Vuletić L; Spuzić I
    Neoplasma; 1992; 39(5):299-304. PubMed ID: 1436244
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Epidermal growth factor receptor-negative tumors are predominantly confined to the subgroup of estradiol receptor-positive human primary breast cancers.
    Koenders PG; Beex LV; Geurts-Moespot A; Heuvel JJ; Kienhuis CB; Benraad TJ
    Cancer Res; 1991 Sep; 51(17):4544-8. PubMed ID: 1873798
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Intracystic papillary carcinoma of the breast: report of three cases].
    El mazghi A; Bouhafa T; Loukili K; El kacemi H; Lalya I; Kebdani T; Hassouni K
    Pan Afr Med J; 2014; 18():207. PubMed ID: 25419333
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Association among an autocrine parameter (EGF-R) and endocrine parameters (ER and PR) in locoregional breast cancer.
    Nikolić-Vukosavljević D; Kanjer K; Branković-Magić M; Spuzić I
    Neoplasma; 1994; 41(3):137-40. PubMed ID: 7935980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.